In our present study, we aimed to investigate the effect of Lova alone and the combination Duta + Lova on cell viability as well as PSMA and AR expression in three established prostate cancer cell lines (LNCaP, C4-2 and VCaP). This evidence concerns the gene FOLH1 and prostate carcinoma.